Page 2 - Pfizer Phase News Today

It's becoming more and more apparent as to why Pfizer tried - albeit unsuccessfully - to withhold their ...

Peter Doshi and colleagues' heroic attempt at re-analysis of the Phase 3 trials. There has been a bit of a stir lately concerning the posting at the beginning of this month of a pre-print (not yet peer reviewed) article entitled "Serious Adverse...

The case reports included in Pfizer clinical trial documents, released June 1 by the U.S. Food and Drug ...

The Phase III trials saw 75 percent of women in the relugolix combination therapy group achieve a reduction in dysmenorrhea (menstrual pain).

The NBC News tool we wrote about last week, Brandy Zadrozny, is now the standard of comparison for vaxx zealots on this blog. This person, who is also a pedophile supporter, tells the vaxx zealot [...]

A new independent study using analysis of excess deaths showed that our estimate of the number of excess deaths was consistent with what they found. (Article by Steve Kirsch republished from [...]

 Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, has taken a deep-dive into the U.S. Vaccine Adverse Events Reporting System (VAERS), and in this interview she shares the details of what she’s finding. VAERS, despite flaws and drawbacks, is one of the greatest tools we have to evaluate vaccine safety. It was implemented as a consequence of the 1986 National Childhood Vaccine Injury Act. While vaccine companies were given blanket immunity aga...

 Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, has taken a deep-dive into the U.S. Vaccine Adverse Events Reporting System (VAERS), and in this interview she shares the details of what she’s finding. VAERS, despite flaws and drawbacks, is one of the greatest tools we have to evaluate vaccine safety. It was implemented as a consequence of the 1986 National Childhood Vaccine Injury Act. While vaccine companies were given blanket immunity aga...

Jessica Rose, Ph.D., a research fellow at the Institute for Pure and Applied Knowledge in Israel, has taken a deep-dive into the U.S. Vaccine Adverse Events Reporting System (VAERS), and in this interview she shares the details of what she's...

—Seeking the Grail Remember when the pandemic started and we were all, “OMG! Give us a vaccine!” and science was like, “OK, but it takes 15 years,” and everybody was like, “Nuh-uh, NOW! Just skip some steps!” and science was like, “Umm...?” Well, here we are! From a distance, it seems scientists take an almost masochistic pride in being uncertain about stuff any normal person would consider a lead-pipe cinch. The Pfizer Phase 3 trial had 43,000 subjects—how much more sure ...